When co-activated, these pathways yield a harmonized metabolic response characterized by enhanced energy utilization, reduced fat mass, and improved glycemic control
Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)
Approval is expected in late 2026 to early 2027, with Canadian availability following
If your hair is freshly colored or chemically treated, follow your stylist's guidance on introducing new products
GLP-1 is produced through the proteolytic processing of proglucagon, promoting insulin secretion while inhibiting glucagon production